Zydus Lifesciences gets FDA approval for Estradiol Transdermal System

Zydus Lifesciences gets FDA approval for Estradiol Transdermal System

Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day from the US Food and Drug Administration (FDA). The approved product is a generic version of Vivelle-Dot Transdermal System. Estradiol Transdermal System has FDA approval for the treatment of moderate […]

Lupin Pharmaceuticals gets FDA approval for SOLOSEC sNDA

Lupin Pharmaceuticals gets FDA approval for SOLOSEC sNDA

Lupin Pharmaceuticals has secured approval from the US Food and Drug Administration for its supplemental new drug application (sNDA) to expand the indication of SOLOSEC (secnidazole) in the treatment of bacterial vaginosis (BV) for female patients, aged 12 and more and in the treatment of trichomoniasis for all patients, aged 12 and more. Bacterial vaginosis […]

Gilead Sciences bags Descovy FDA approval for prevention of HIV infection

Gilead Sciences bags Descovy FDA approval for prevention of HIV infection

Descovy FDA approval : Gilead Sciences’ Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) has been approved by the US Food and Drug Administration for HIV Pre-Exposure Prophylaxis (PrEP) or in other words prevention of HIV infection.. PrEP is defined as an HIV prevention method in which medicine is taken everyday before […]